UB-421
Showing 1 - 25 of 55
Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases
Not yet recruiting
- Multi-Drug Resistant Hiv-1 Infection
- HIV-1 Infection
- UB-421
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
HIV-1 Infection Trial in Kaohsiung City, Taiwan (UB-421, chidamide)
Recruiting
- HIV-1 Infection
- UB-421
- chidamide
-
Kaohsiung City, Taiwan, TaiwanKaohsiung Veterans General Hospital
Aug 25, 2022
HIV-1-infection Trial (UB-421 SC)
Not yet recruiting
- HIV-1-infection
- UB-421 SC
- (no location specified)
May 12, 2022
HIV-1 Infection Trial in Kaohsiung City (UB-421 SC(dB4C7C22-6 mAb))
Recruiting
- HIV-1 Infection
- UB-421 SC(dB4C7C22-6 mAb)
-
Kaohsiung City, TaiwanKaohsiung Veterans General Hospital
May 12, 2022
HIV-1-infection Trial (UB-421, UB-421+chidamide)
Not yet recruiting
- HIV-1-infection
- UB-421
- UB-421+chidamide
- (no location specified)
Jul 25, 2021
HIV-1 Infection Trial (UB-421, Antiretroviral Therapy (ART))
Withdrawn
- HIV-1 Infection
- UB-421
- Antiretroviral Therapy (ART)
- (no location specified)
Feb 18, 2020
Urinary Bladder Wall Post Transurethral Tumor Resection
Not yet recruiting
- Urinary Bladder Cancer
- MRI
- (no location specified)
Mar 15, 2023
Migraine Trial in Leuven (UB-313, Placebo)
Recruiting
- Migraine
- UB-313
- Placebo
-
Leuven, BelgiumKatholieke Universiteit Leuven
Jul 25, 2022
Multiple System Atrophy, Parkinson Disease Trial in New York (UB-312 Injection, Placebo Injection)
Not yet recruiting
- Multiple System Atrophy
- Parkinson Disease
- UB-312 Injection
- Placebo Injection
-
New York, New YorkNYU Langone Health
Nov 23, 2022
es to Delirium Identification-Sustaining Effective Translation
Not yet recruiting
- Delirium
- +3 more
- (no location specified)
Jun 21, 2023
COVID-19 Trial in Taichung (UB-612)
Completed
- COVID-19
- UB-612
-
Taichung, TaiwanChina Medical University Hospital
Feb 11, 2022
COVID-19 Vaccines Trial in Panama, Philippines, United States (UB-612, BNT162b2 vaccine, ChAdOx1-S vaccine)
Active, not recruiting
- COVID-19 Vaccines
- UB-612
- +3 more
-
Brownsville, Texas
- +6 more
Oct 11, 2022
COVID-19 Trial in Taichung (UB-612)
Completed
- COVID-19
- UB-612
-
Taichung, TaiwanChina Medical University Hospital
Aug 25, 2022
Recurrent Genital Herpes Trial (UB-621)
Not yet recruiting
- Recurrent Genital Herpes
- UB-621
- (no location specified)
May 16, 2022
Upper Blepharoplasty on Vision Quality in Early Postoperative
Recruiting
- Excess Skin of Both Eyelids
- +3 more
- Upper blepharoplasty
-
Osijek, CroatiaOsijek University Hospital
Sep 21, 2022
Osteosarcoma Trial in Seattle (SCRI-E2CAR_EGFRtv1, UB_TT170)
Recruiting
- Osteosarcoma
- SCRI-E2CAR_EGFRtv1
- UB_TT170
-
Seattle, WashingtonSeattle Children's Hospital
May 31, 2022
Smoking, Tobacco Use, Electronic Cigarette Use Trial in United States (P1211216, P1213416, P1213716)
Recruiting
- Smoking
- +2 more
- P1211216
- +15 more
-
Stockbridge, Georgia
- +3 more
Jun 23, 2022
Recurrent Genital Herpes Trial (Placebo, UB-621 low-dose, UB-621 high-dose)
Not yet recruiting
- Recurrent Genital Herpes
- Placebo
- +2 more
- (no location specified)
Jul 19, 2021
Covid-19, SARS-CoV-2, Coronavirus Trial (UB-612, Placebo)
Withdrawn
- Covid-19
- +2 more
- UB-612
- Placebo
- (no location specified)
Mar 21, 2022
Validation of the 3D-CAM and the UB-CAM in French
Recruiting
- Delirium
- Delirium screening using 3D-CAM and UB-CAM
-
Villeurbanne, Lyon, FranceHôpital des Charpennes, Institut du Vieillissement, Hospices Civ
Jul 6, 2022
COVID-19 Trial (UB-612)
Withdrawn
- COVID-19
- UB-612
- (no location specified)
Feb 13, 2022
Breast Cancer Trial in Reykjavik (A digital care solution for patients with Breast Cancer)
Recruiting
- Breast Cancer
- A digital care solution for patients with Breast Cancer
-
Reykjavik, IcelandLjosið Rehabilitation Centre
Jul 25, 2022
COVID-19 Trial in Taiwan (UB-612, Placebo)
Terminated
- COVID-19
- UB-612
- Placebo
-
Changhua, Taiwan
- +11 more
Jun 13, 2022
Parkinson's Disease, Parkinsonism Trial in Leiden (UB-312, Placebo)
Active, not recruiting
- Parkinson's Disease
- Parkinsonism
- UB-312
- Placebo
-
Leiden, NetherlandsCentre for Human Drug Research
May 3, 2022
HIV-1 Infection Trial in Taipei (UB-421)
Completed
- HIV-1 Infection
- UB-421
-
Taipei, TaiwanTaipei Veterans General Hospital
Oct 29, 2017